Regeneron Pharmaceuticals
REGN
#157
Rank
$91.05 B
Marketcap
$835.75
Share price
1.81%
Change (1 day)
11.81%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2023 (TTM): $4.37 B

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.37 B. In 2022 the company made an earning of $4.85 B a decrease over its 2021 earnings that were of $9.32 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$4.37 B-9.93%
2022$4.85 B-47.9%
2021$9.32 B144.75%
2020$3.81 B56.86%
2019$2.42 B-4.87%
2018$2.55 B22.85%
2017$2.07 B56.3%
2016$1.32 B8.55%
2015$1.22 B57.92%
2014$0.77 B8.75%
2013$0.71 B72.13%
2012$0.41 B-285.93%
2011-$0.23 B121.3%
2010-$0.11 B30.6%
2009-$77.13 M-9.88%
2008-$85.59 M-25.23%
2007-$0.12 B6.32%
2006-$0.11 B-186.52%
2005$0.12 B2103.7%
2004$5.64 M-105.75%
2003-$98.16 M-19.52%
2002-$0.13 B47.09%
2001-$82.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$24.43 B 458.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.80 B 101.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$8.75 B 99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.77 B 146.25%๐Ÿ‡ซ๐Ÿ‡ท France
$1.60 B-63.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.39 B-108.75%๐Ÿ‡บ๐Ÿ‡ธ USA